0.55% 0.04

Diamedica Therapeutics Inc (DMAC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	10.56% 6.437	5.822	5.656	6.47	4.983
Operating Income/Loss	12.81% -9.033	-8.007	-8.144	-8.419	-6.883
Nonoperating Income/Loss	33.44% 0.419	0.314	0.443	-	-
Income/Loss From Continuing Operations Before Tax	11.97% -8.614	-7.693	-7.701	-7.891	-6.267
Income Tax Expense/Benefit	0.00% 0.006	0.006	0.006	0.009	0.007
Income/Loss From Continuing Operations After Tax	11.96% -8.62	-7.699	-7.707	-7.90	-6.274
Net Income/Loss	11.96% -8.62	-7.699	-7.707	-7.90	-6.274
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	15.53% 49.63	42.96	42.84	0.8005	42.75
Basic Earnings Per Share	5.56% -0.17	-0.18	-0.18	-0.18	-0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%